Design, synthesis, and study of novel phenethyl-based antitumor phospholipids downregulating p38 mitogen-activated protein kinase

AbstractPhenethyl-based edelfosine-analogs with saturated, monounsaturated, or polyunsaturated alkoxy substituents on phenyl ring were designed as novel antitumor lipids modulating p38 MAPK. Evaluation of the synthesised compounds against nine panels of diverse cancer cells presented saturated and m...

Full description

Bibliographic Details
Main Authors: Ahmed H. E. Hassan, Yeon Il Oh, Chae Hyeon Lee, Yeon Ju Kim, Soo Bin Cho, Md. Maqusood Alam, Sang-Eun Park, Kyung-Sook Chung, Kyung-Tae Lee, Yong Sup Lee
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2023.2217695
_version_ 1797400971924471808
author Ahmed H. E. Hassan
Yeon Il Oh
Chae Hyeon Lee
Yeon Ju Kim
Soo Bin Cho
Md. Maqusood Alam
Sang-Eun Park
Kyung-Sook Chung
Kyung-Tae Lee
Yong Sup Lee
author_facet Ahmed H. E. Hassan
Yeon Il Oh
Chae Hyeon Lee
Yeon Ju Kim
Soo Bin Cho
Md. Maqusood Alam
Sang-Eun Park
Kyung-Sook Chung
Kyung-Tae Lee
Yong Sup Lee
author_sort Ahmed H. E. Hassan
collection DOAJ
description AbstractPhenethyl-based edelfosine-analogs with saturated, monounsaturated, or polyunsaturated alkoxy substituents on phenyl ring were designed as novel antitumor lipids modulating p38 MAPK. Evaluation of the synthesised compounds against nine panels of diverse cancer cells presented saturated and monounsaturated alkoxy-substituted derivatives as the most active than other derivatives. In addition, ortho-substituted compounds were more active than meta- or ortho-substituted compounds. They were potential anticancer agents against blood, lung, colon, CNS, ovary, renal, and prostate cancers but not against skin nor breast cancers. Compounds, 1b and 1a emerged as the most potential anticancer agents. Assessment of compound 1b impact on p38 MAPK and AKT confirmed it as an inhibitor of p38 MAPK but not AKT. In silico study suggested compounds 1b and 1a as possible binders to the lipid binding pocket of p38 MAPK. Overall, compounds 1b and 1a as novel broad spectrum antitumor lipids modulating activity of p38 MAPK for further development.
first_indexed 2024-03-09T02:03:11Z
format Article
id doaj.art-c593553338f64ac58bc7690f590ec50e
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-03-09T02:03:11Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-c593553338f64ac58bc7690f590ec50e2023-12-08T03:24:21ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742023-12-0138110.1080/14756366.2023.2217695Design, synthesis, and study of novel phenethyl-based antitumor phospholipids downregulating p38 mitogen-activated protein kinaseAhmed H. E. Hassan0Yeon Il Oh1Chae Hyeon Lee2Yeon Ju Kim3Soo Bin Cho4Md. Maqusood Alam5Sang-Eun Park6Kyung-Sook Chung7Kyung-Tae Lee8Yong Sup Lee9Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, EgyptDepartment of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Republic of KoreaDepartment of Fundamental Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of KoreaDepartment of Fundamental Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of KoreaDepartment of Fundamental Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of KoreaDepartment of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Republic of KoreaDepartment of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Seoul, Republic of KoreaDepartment of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Seoul, Republic of KoreaDepartment of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Seoul, Republic of KoreaMedicinal Chemistry Laboratory, Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, Republic of KoreaAbstractPhenethyl-based edelfosine-analogs with saturated, monounsaturated, or polyunsaturated alkoxy substituents on phenyl ring were designed as novel antitumor lipids modulating p38 MAPK. Evaluation of the synthesised compounds against nine panels of diverse cancer cells presented saturated and monounsaturated alkoxy-substituted derivatives as the most active than other derivatives. In addition, ortho-substituted compounds were more active than meta- or ortho-substituted compounds. They were potential anticancer agents against blood, lung, colon, CNS, ovary, renal, and prostate cancers but not against skin nor breast cancers. Compounds, 1b and 1a emerged as the most potential anticancer agents. Assessment of compound 1b impact on p38 MAPK and AKT confirmed it as an inhibitor of p38 MAPK but not AKT. In silico study suggested compounds 1b and 1a as possible binders to the lipid binding pocket of p38 MAPK. Overall, compounds 1b and 1a as novel broad spectrum antitumor lipids modulating activity of p38 MAPK for further development.https://www.tandfonline.com/doi/10.1080/14756366.2023.2217695Antitumor lipidsPhospholipidsCancerp38 MAPK 
spellingShingle Ahmed H. E. Hassan
Yeon Il Oh
Chae Hyeon Lee
Yeon Ju Kim
Soo Bin Cho
Md. Maqusood Alam
Sang-Eun Park
Kyung-Sook Chung
Kyung-Tae Lee
Yong Sup Lee
Design, synthesis, and study of novel phenethyl-based antitumor phospholipids downregulating p38 mitogen-activated protein kinase
Journal of Enzyme Inhibition and Medicinal Chemistry
Antitumor lipids
Phospholipids
Cancer
p38 MAPK 
title Design, synthesis, and study of novel phenethyl-based antitumor phospholipids downregulating p38 mitogen-activated protein kinase
title_full Design, synthesis, and study of novel phenethyl-based antitumor phospholipids downregulating p38 mitogen-activated protein kinase
title_fullStr Design, synthesis, and study of novel phenethyl-based antitumor phospholipids downregulating p38 mitogen-activated protein kinase
title_full_unstemmed Design, synthesis, and study of novel phenethyl-based antitumor phospholipids downregulating p38 mitogen-activated protein kinase
title_short Design, synthesis, and study of novel phenethyl-based antitumor phospholipids downregulating p38 mitogen-activated protein kinase
title_sort design synthesis and study of novel phenethyl based antitumor phospholipids downregulating p38 mitogen activated protein kinase
topic Antitumor lipids
Phospholipids
Cancer
p38 MAPK 
url https://www.tandfonline.com/doi/10.1080/14756366.2023.2217695
work_keys_str_mv AT ahmedhehassan designsynthesisandstudyofnovelphenethylbasedantitumorphospholipidsdownregulatingp38mitogenactivatedproteinkinase
AT yeoniloh designsynthesisandstudyofnovelphenethylbasedantitumorphospholipidsdownregulatingp38mitogenactivatedproteinkinase
AT chaehyeonlee designsynthesisandstudyofnovelphenethylbasedantitumorphospholipidsdownregulatingp38mitogenactivatedproteinkinase
AT yeonjukim designsynthesisandstudyofnovelphenethylbasedantitumorphospholipidsdownregulatingp38mitogenactivatedproteinkinase
AT soobincho designsynthesisandstudyofnovelphenethylbasedantitumorphospholipidsdownregulatingp38mitogenactivatedproteinkinase
AT mdmaqusoodalam designsynthesisandstudyofnovelphenethylbasedantitumorphospholipidsdownregulatingp38mitogenactivatedproteinkinase
AT sangeunpark designsynthesisandstudyofnovelphenethylbasedantitumorphospholipidsdownregulatingp38mitogenactivatedproteinkinase
AT kyungsookchung designsynthesisandstudyofnovelphenethylbasedantitumorphospholipidsdownregulatingp38mitogenactivatedproteinkinase
AT kyungtaelee designsynthesisandstudyofnovelphenethylbasedantitumorphospholipidsdownregulatingp38mitogenactivatedproteinkinase
AT yongsuplee designsynthesisandstudyofnovelphenethylbasedantitumorphospholipidsdownregulatingp38mitogenactivatedproteinkinase